A phase II clinical trial of talazoparib monotherapy for PALB2 mutation-associated advanced breast cancer. Gruber, J., Gross, W., McMillan, A., Ford, J. M., Telli, M. L. LIPPINCOTT WILLIAMS & WILKINS. 2021

View details for DOI 10.1200/JCO.2021.39.15_suppl.TPS1109

View details for Web of Science ID 000708120306163